Suchergebnisse - "Pinato, David J"

PubPharm (22)

1

Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT) : from premalignant to metastatic disease

enthalten in: Journal for immunotherapy of cancer | 2024

von Luke, J. | Davar, D. | Andtbacka, R. | +23

2

Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer : Results of a propensity-matched analysis of the OnCovid registry

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2024

von Mostaghim, A. | Minkove, S. | Aguilar-Company, J. | +43

3

Treatment-emergent antidrug antibodies related to PD-1, PD-L1, or CTLA-4 inhibitors across tumor types : a systematic review

enthalten in: Journal for immunotherapy of cancer | 2024

von Galle, P. | Finn, R. | Mitchell, C. | +4

4

Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC) : "Real World" Experience

enthalten in: Clinical genitourinary cancer | 2023

von Bakaloudi, D. | Talukder, R. | Lin, G. | +32

5

Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma

enthalten in: Hepatology international | 2023

von Vithayathil, M. | D'Alessio, A. | Fulgenzi, C. | +32

CommentIn: Hepatol Int. 2023 Aug;17(4):827-829. - PMID 37188999

6

A Novel Radiogenomics Biomarker for Predicting Treatment Response and Pneumotoxicity From Programmed Cell Death Protein or Ligand-1 Inhibition Immunotherapy in NSCLC

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Chen, M. | Lu, H. | Copley, S. | +7

CommentIn: J Thorac Oncol. 2023 Jun;18(6):686-688. - PMID 37210178

7

Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma

enthalten in: JHEP reports : innovation in hepatology | 2023

von Scheiner, B. | Roessler, D. | Phen, S. | +35

8

Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma

enthalten in: Clinical genitourinary cancer | 2022

von Talukder, R. | Makrakis, D. | Lin, G. | +51

9

Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer

enthalten in: Cancer treatment reviews | 2022

von Schettini, F. | Venturini, S. | Giuliano, M. | +27

10

Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer : a joint analysis of OnCovid and ESMO-CoCARE registries

enthalten in: Journal for immunotherapy of cancer | 2022

von Cortellini, A. | Dettorre, G. | Dafni, U. | +40